Roszdravnadzor’s plans to impose tighter price controls on vital drugs are beneficial for players in the pharmaceutical market, says RNC Pharma development director Nikolai Bespalov. Such control already exists in some form, but it needs automation. stated The analyst is chatting with 360 TV channel.
Nowadays, errors occur because the cost of medicines is regulated manually. Bespalov emphasized that Roszdravnadzor’s plans are primarily concerned with the creation of an automated tool that will prevent inflating prices of vital drugs and prevent violations of the law.
“I think pharmacies and all market participants will benefit from this,” he said.
Bespalov also emphasized that it is important to ensure the quality and transparent functioning of the relevant mechanism, otherwise dangerous failures for market players may be possible.
Let us recall that it was reported that Roszdravnadzor plans to create a mechanism for monitoring drug prices, in which all data on the cost of drugs will be entered into a special monitoring system.
Ministry of Health at the beginning of February reported Regarding the increase in prices of vital medicines, however, the increase remained within the inflation range. The ministry emphasized that they control the cost of drugs and their availability on the Russian market.
Previously recognizedRussians are less likely to purchase the popular drug.